SCHEMBL4969583

SCHEMBL4969583

Cc1cccc(NC(=O)O)c1CNc1cccn2c(C=O)c(C)nc12

nearest known ligand 0.57

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 18/20 0.57
CYP2C9 P11712 18/20 0.57
CYP2D6 P10635 10/20 0.57
CYP2C19 P33261 8/20 0.57
CYP1A2 P05177 7/20 0.57
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8136776 0.92 CYP3A4 (0.53) CYP3A4CYP2C9CYP2D6CYP2C19CYP1A2
SCHEMBL8804870 0.90 CYP3A4 (0.51) CYP3A4CYP2C9CYP2D6CYP2C19CYP1A2
SCHEMBL8806511 0.87 CYP2C9 (0.48) CYP3A4CYP2C9CYP2D6CYP2C19CYP1A2
SCHEMBL7499692 0.87 CYP3A4 (0.48) CYP3A4CYP2C9CYP2D6CYP2C19CYP1A2
SCHEMBL7505182 0.86 CYP3A4 (0.47) CYP3A4CYP2C9CYP2D6CYP2C19CYP1A2
SCHEMBL7828059 0.86 CYP3A4 (0.47) CYP3A4CYP2C9CYP2D6CYP2C19CYP1A2
SCHEMBL7509329 0.85 CYP3A4 (0.56) CYP3A4CYP2C9CYP2D6CYP2C19CYP1A2
SCHEMBL4970701 0.83 CYP3A4 (0.57) CYP3A4CYP2C9CYP2D6CYP2C19CYP1A2
SCHEMBL8806324 0.83 CYP3A4 (0.44) CYP3A4CYP2C9CYP2D6CYP2C19CYP1A2
SCHEMBL6351638 0.78 CYP3A4 (0.59) CYP3A4CYP2C9CYP2D6CYP2C19CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1934215-A1 ISOTOPICALLY SUBSTITUTED IMIDAZOPYRIDINE DERIVATIVES FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS Nycomed GmbH (DE) 2008-06-25 EP disclosed
WO-2007039464-A1 ISOTOPICALLY SUBSTITUTED IMIDAZOPYRIDINE DERIVATIVES FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS NYCOMED GMBH (DE) 2007-04-12 WO disclosed